Cargando…
COVID-19 Epidemiology during Delta Variant Dominance Period in 45 High-Income Countries, 2020–2021
The SARS-CoV-2 Delta variant, first identified in October 2020, quickly became the dominant variant worldwide. We used publicly available data to explore the relationship between illness and death (peak case rates, death rates, case-fatality rates) and selected predictors (percentage vaccinated, per...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461680/ https://www.ncbi.nlm.nih.gov/pubmed/37494699 http://dx.doi.org/10.3201/eid2909.230142 |
_version_ | 1785097889226162176 |
---|---|
author | Atherstone, Christine J. Guagliardo, Sarah Anne J. Hawksworth, Anthony O’Laughlin, Kevin Wong, Kimberly Sloan, Michelle L. Henao, Olga Rao, Carol Y. McElroy, Peter D. Bennett, Sarah D. |
author_facet | Atherstone, Christine J. Guagliardo, Sarah Anne J. Hawksworth, Anthony O’Laughlin, Kevin Wong, Kimberly Sloan, Michelle L. Henao, Olga Rao, Carol Y. McElroy, Peter D. Bennett, Sarah D. |
author_sort | Atherstone, Christine J. |
collection | PubMed |
description | The SARS-CoV-2 Delta variant, first identified in October 2020, quickly became the dominant variant worldwide. We used publicly available data to explore the relationship between illness and death (peak case rates, death rates, case-fatality rates) and selected predictors (percentage vaccinated, percentage of the population >65 years, population density, testing volume, index of mitigation policies) in 45 high-income countries during the Delta wave using rank-order correlation and ordinal regression. During the Delta-dominant period, most countries reported higher peak case rates (57%) and lower peak case-fatality rates (98%). Higher vaccination coverage was protective against peak case rates (odds ratio 0.95, 95% CI 0.91–0.99) and against peak death rates (odds ratio 0.96, 95% CI 0.91–0.99). Vaccination coverage was vital to preventing infection and death from COVID-19 during the Delta wave. As new variants emerge, public health authorities should encourage the uptake of COVID-19 vaccination and boosters. |
format | Online Article Text |
id | pubmed-10461680 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-104616802023-09-01 COVID-19 Epidemiology during Delta Variant Dominance Period in 45 High-Income Countries, 2020–2021 Atherstone, Christine J. Guagliardo, Sarah Anne J. Hawksworth, Anthony O’Laughlin, Kevin Wong, Kimberly Sloan, Michelle L. Henao, Olga Rao, Carol Y. McElroy, Peter D. Bennett, Sarah D. Emerg Infect Dis Research The SARS-CoV-2 Delta variant, first identified in October 2020, quickly became the dominant variant worldwide. We used publicly available data to explore the relationship between illness and death (peak case rates, death rates, case-fatality rates) and selected predictors (percentage vaccinated, percentage of the population >65 years, population density, testing volume, index of mitigation policies) in 45 high-income countries during the Delta wave using rank-order correlation and ordinal regression. During the Delta-dominant period, most countries reported higher peak case rates (57%) and lower peak case-fatality rates (98%). Higher vaccination coverage was protective against peak case rates (odds ratio 0.95, 95% CI 0.91–0.99) and against peak death rates (odds ratio 0.96, 95% CI 0.91–0.99). Vaccination coverage was vital to preventing infection and death from COVID-19 during the Delta wave. As new variants emerge, public health authorities should encourage the uptake of COVID-19 vaccination and boosters. Centers for Disease Control and Prevention 2023-09 /pmc/articles/PMC10461680/ /pubmed/37494699 http://dx.doi.org/10.3201/eid2909.230142 Text en https://creativecommons.org/licenses/by/4.0/Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Research Atherstone, Christine J. Guagliardo, Sarah Anne J. Hawksworth, Anthony O’Laughlin, Kevin Wong, Kimberly Sloan, Michelle L. Henao, Olga Rao, Carol Y. McElroy, Peter D. Bennett, Sarah D. COVID-19 Epidemiology during Delta Variant Dominance Period in 45 High-Income Countries, 2020–2021 |
title | COVID-19 Epidemiology during Delta Variant Dominance Period in 45 High-Income Countries, 2020–2021 |
title_full | COVID-19 Epidemiology during Delta Variant Dominance Period in 45 High-Income Countries, 2020–2021 |
title_fullStr | COVID-19 Epidemiology during Delta Variant Dominance Period in 45 High-Income Countries, 2020–2021 |
title_full_unstemmed | COVID-19 Epidemiology during Delta Variant Dominance Period in 45 High-Income Countries, 2020–2021 |
title_short | COVID-19 Epidemiology during Delta Variant Dominance Period in 45 High-Income Countries, 2020–2021 |
title_sort | covid-19 epidemiology during delta variant dominance period in 45 high-income countries, 2020–2021 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461680/ https://www.ncbi.nlm.nih.gov/pubmed/37494699 http://dx.doi.org/10.3201/eid2909.230142 |
work_keys_str_mv | AT atherstonechristinej covid19epidemiologyduringdeltavariantdominanceperiodin45highincomecountries20202021 AT guagliardosarahannej covid19epidemiologyduringdeltavariantdominanceperiodin45highincomecountries20202021 AT hawksworthanthony covid19epidemiologyduringdeltavariantdominanceperiodin45highincomecountries20202021 AT olaughlinkevin covid19epidemiologyduringdeltavariantdominanceperiodin45highincomecountries20202021 AT wongkimberly covid19epidemiologyduringdeltavariantdominanceperiodin45highincomecountries20202021 AT sloanmichellel covid19epidemiologyduringdeltavariantdominanceperiodin45highincomecountries20202021 AT henaoolga covid19epidemiologyduringdeltavariantdominanceperiodin45highincomecountries20202021 AT raocaroly covid19epidemiologyduringdeltavariantdominanceperiodin45highincomecountries20202021 AT mcelroypeterd covid19epidemiologyduringdeltavariantdominanceperiodin45highincomecountries20202021 AT bennettsarahd covid19epidemiologyduringdeltavariantdominanceperiodin45highincomecountries20202021 |